BROOMFIELD, Colo., Aug. 1 /PRNewswire/ -- ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, announced today that it has appointed James Carr, PharmD, as ...
- Recent posts
- ARCA biopharma Appoints James Carr as Vice President of Marketing - Forbes
- Jury acquits Gupta - Dayton Daily News
- New Medicade rules for hospice patients: ‘simple changes … big ... - Olympian
- Suffering and Chronic Pain Management
- Canadian Pain Society, mdBriefCase and AdvancingIn Team up to Provide ... - CNW Group
- Pain Relief
- Bonica's Management of Pain
- Jack Coleman and Brandy Are the Newest Stars in Skechers' Charity ... - Forbes
- PRG-Schultz International, Inc. to Hold Second Quarter 2008 Financial ... - MSN MoneyCentral
- Xanodyne's Zipsor on track for FDA approval - Business Courier
- Pain management/ able to continue working?
- Patients speak out on behalf of RapidCare doctor under scrutiny for ... - DL-Online
- Pain Management Clinics?
- Chiropractor authors book about back pain management - Batavia Sun
- Fibromyalgia Pain Management Option: Hydrotherapy
- NHS told it must help patients to choose where and how to die - Times Online
- Pain management vexes patients, docs
- Optimizing Pain Control With Fentanyl Patches - Medscape News
- Port Richey physician convicted of child porn - St. Petersburg Times
- How to keep your kids pain-free - CNN